The Febrile Neutropenia Market trends indicate a transformative shift driven by rising chemotherapy treatments and the increasing prevalence of febrile neutropenia globally. The market is witnessing significant evolution due to advanced therapeutics, biosimilars, and patient-centric care models. Hospitals and oncology centers are at the forefront of implementing these treatment strategies,...